Oxfordshire, United Kingdom

Alastair David Graham Donald

USPTO Granted Patents = 5 


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2015-2017

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Alastair David Graham Donald: Innovator in Medicinal Chemistry

Introduction

Alastair David Graham Donald is a notable inventor based in Oxfordshire, Great Britain. He has made significant contributions in the field of medicinal chemistry, particularly through his innovative patents that focus on enzyme and receptor modulation. With a total of five patents to his name, Donald showcases his expertise and commitment to advancing scientific knowledge.

Latest Patents

Among Alastair Donald's latest patents is a formulation that covers HDAC inhibitors, specifically compounds that inhibit HDAC activity with a detailed structural formula. These compounds involve versatile components that allow for various modifications in their molecular design. Another notable patent revolves around enzyme and receptor modulation utilizing covalent conjugates of alpha,alpha-disubstituted glycine esters. This innovative creation describes how such conjugates can enhance the efficacy of intracellular modulating agents, allowing for targeted cellular entry and the accumulation of active hydrolysis products.

Career Highlights

Throughout his career, Alastair David Graham Donald has been associated with leading companies in the pharmaceutical sector, including GlaxoSmithKline Intellectual Property Development Limited and Chroma Therapeutics Limited. His work with these organizations has allowed him to translate research concepts into viable patents, further influencing the field of medicinal chemistry.

Collaborations

Alastair has collaborated with prominent professionals in his field, including David Festus Charles Moffat and Alan Hornsby Davidson. These collaborations have surely contributed to the successful development of his innovative patents, merging diverse expertise to push the boundaries of medicinal research.

Conclusion

With a strong foundation in inventiveness and collaboration, Alastair David Graham Donald continues to make impactful strides in the realm of medicinal chemistry. His five patents, particularly in the areas of HDAC inhibitors and enzyme modulation, not only reflect his ingenuity but also pave the way for future advancements in therapeutic approaches.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…